Home
/
IRADIMED CORP
/
Financials
/
Quarterly
IRADIMED CORP — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that IRADIMED CORP filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$21.20M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$20.41M
Aug 1, 2025
Q1
2025
Mar 31, 2025
$19.51M
May 5, 2025
Q3
2025
Sep 30, 2024
$18.33M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$17.93M
Aug 1, 2025
Q1
2025
Mar 31, 2024
$17.60M
May 5, 2025
Q3
2024
Sep 30, 2023
$16.50M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$16.13M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$15.48M
May 2, 2024
Q3
2023
Sep 30, 2022
$13.41M
Nov 3, 2023
Q2
2023
Jun 30, 2022
$12.72M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$12.31M
May 4, 2023
Q3
2022
Sep 30, 2021
$10.91M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$9.81M
Aug 5, 2022
Q1
2022
Mar 31, 2021
$9.22M
May 6, 2022
Q3
2021
Sep 30, 2020
$7.70M
Nov 5, 2021
Q2
2021
Jun 30, 2020
$6.79M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$8.68M
May 7, 2021
Q3
2020
Sep 30, 2019
$9.96M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$9.23M
Aug 6, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$21.20M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$20.41M
Aug 1, 2025
Q1
2025
Mar 31, 2025
$19.51M
May 5, 2025
Q3
2025
Sep 30, 2024
$18.33M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$17.93M
Aug 1, 2025
Q1
2025
Mar 31, 2024
$17.60M
May 5, 2025
Q3
2024
Sep 30, 2023
$16.50M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$16.13M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$15.48M
May 2, 2024
Q3
2023
Sep 30, 2022
$13.41M
Nov 3, 2023
Q2
2023
Jun 30, 2022
$12.72M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$12.31M
May 4, 2023
Q3
2022
Sep 30, 2021
$10.91M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$9.81M
Aug 5, 2022
Q1
2022
Mar 31, 2021
$9.22M
May 6, 2022
Q3
2021
Sep 30, 2020
$7.70M
Nov 5, 2021
Q2
2021
Jun 30, 2020
$6.79M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$8.68M
May 7, 2021
Q3
2020
Sep 30, 2019
$9.96M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$9.23M
Aug 6, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$5.58M
Nov 3, 2025
Q3
2025
Jun 30, 2025
$5.77M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$5.77M
Aug 1, 2025
Q1
2025
Mar 31, 2025
$4.69M
May 5, 2025
Q3
2025
Mar 31, 2025
$4.69M
Nov 3, 2025
Q2
2025
Mar 31, 2025
$4.69M
Aug 1, 2025
Q3
2025
Sep 30, 2024
$5.05M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$4.90M
Aug 1, 2025
Q3
2025
Jun 30, 2024
$4.90M
Nov 3, 2025
Q1
2025
Mar 31, 2024
$4.14M
May 5, 2025
Q3
2025
Mar 31, 2024
$4.14M
Nov 3, 2025
Q2
2025
Mar 31, 2024
$4.14M
Aug 1, 2025
Q3
2024
Sep 30, 2023
$5.07M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$4.18M
Aug 1, 2024
Q3
2024
Jun 30, 2023
$4.18M
Oct 31, 2024
Q2
2024
Mar 31, 2023
$3.41M
Aug 1, 2024
Q3
2024
Mar 31, 2023
$3.41M
Oct 31, 2024
Q1
2024
Mar 31, 2023
$3.41M
May 2, 2024
Q3
2023
Sep 30, 2022
$3.43M
Nov 3, 2023
Q2
2023
Jun 30, 2022
$3.24M
Aug 3, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$6.83M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$6.79M
Aug 1, 2025
Q1
2025
Mar 31, 2025
$5.43M
May 5, 2025
Q3
2025
Sep 30, 2024
$5.79M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$5.63M
Aug 1, 2025
Q1
2025
Mar 31, 2024
$4.75M
May 5, 2025
Q3
2024
Sep 30, 2023
$5.91M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$4.96M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$4.01M
May 2, 2024
Q3
2023
Sep 30, 2022
$4.13M
Nov 3, 2023
Q2
2023
Jun 30, 2022
$4.17M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$3.07M
May 4, 2023
Q3
2022
Sep 30, 2021
$3.09M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$1.84M
Aug 5, 2022
Q1
2022
Mar 31, 2021
$1.78M
May 6, 2022
Q3
2021
Sep 30, 2020
$784.8K
Nov 5, 2021
Q2
2021
Jun 30, 2020
($2.93M)
Aug 6, 2021
Q1
2021
Mar 31, 2020
$737.2K
May 7, 2021
Q3
2020
Sep 30, 2019
$2.52M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$2.38M
Aug 6, 2020